Skip to main content
Equibles

Mariner, LLC

Position in GALT — Galectin Therapeutics Inc

CIK 1373442 Overland Park, KS
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$85,840
+$30,565 QoQ
Shares Held
18,500
-6.6% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 98 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Mariner, LLC holds $491,869,472 across 152 Biotechnology names. GALT ranks #129 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 JAZZ
Jazz Pharmaceuticals plc
 608,615 $146,657,956
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 134,614 $66,866,811
3 REGN
Regeneron Pharmaceuticals, Inc.
 100,086 $62,407,624
4 RPRX
Royalty Pharma plc
 693,495 $38,884,263
5 EXEL
Exelixis, Inc.
 313,083 $17,034,845
6 INCY
Incyte Corp
 121,988 $13,828,559
7 BMRN
Biomarin Pharmaceutical Inc
 192,607 $11,020,972
8 ALNY
Alnylam Pharmaceuticals, Inc.
 28,021 $8,435,161

All Filings in GALT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $85,840 18,500
2026-03-31 $55,275 19,812
2025-12-31 $82,804 19,905
2025-09-30 $116,901 27,571
2025-06-30 $58,041 27,508
2025-03-31 $32,227 26,416
2024-12-31 $35,251 27,327
2024-09-30 $73,108 26,585
2024-06-30 $59,835 26,476
2024-03-31 $67,823 28,378
2023-12-31 $18,057 10,878
2023-09-30 $20,885 10,878
2023-06-30 $15,552 10,800
2023-03-31 $22,680 10,800
2022-12-31 $12,204 10,800
2022-09-30 $18,528 11,367